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Abstract –  A  new  stereoselective  preparation  of  N-aceyl-D-galactosamine  (1b)  starting  from  the  know  p-
methoxyphenyl 3,4-O-isopropylidene-6-O-(1-methoxy-1-methylethyl)-β-D-galactopyranoside (10) is described using a 
simple strategy based on: (a) epimerization at C-2 of  10 via oxidation-reduction to give the  talo derivative  11, (b) 
amination with configurational inversion at C-2 of 11 via a SN2 on its 2-imidazylate, (c) anomeric deprotection of the p-
methoxyphenyl  β-D-galactosamine  glycoside  14,  (d)  complete  deprotection.  Applying  the  same  protocol  to 
2,3:5,6:3’,4’-tri-O-isopropylidene-6’-O-(1-methoxy-1-methylethyl)-lactose  dimethyl  acetal  (4),  directly  obtained 
through  acetonation  of  lactose,  the  disaccharide  β-D-GalNAcp-(1→4)-D-Glcp (1a)  was  obtained  with  complete 
stereoselectivity in good (40%) overall yield from lactose.
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1. Introduction
D-Galactosamine  (D-GalNH2)  is,  after  D-glucosamine,  the  second  most  abundant  natural 
aminosugar,  isolated  first  in  1914  by  Levene  and  La  Forge2 from  chondroitin,  a 
mucopolysaccharide in which D-GalNH2  is present, as in the structurally related dermatan sulfate,3 
as  N-acetamido derivative (2-deoxy-2-acetamido-D-galactopyranose,  D-GalNAc,  1b).  D-GalNAc is 
also  a  constituent  of  several  complex  glycoproteins,  being,  for  examples,  the  monosaccharide 
“core” of mucines,4 a component of oligosaccharide determinants of human blood group antigens,5 
a constituent  of anti-freeze glycoproteins  of anthartic  fishes.5 Furthermore,  D-GalNAc has been 
recently recognised as one of the strongest agonist of the NKR-P1 rat Natural Killer cells receptor.6 
Owing to the biological relevance of D-GalNAc, several approaches to its synthesis in the free form 
and/or to the synthesis of its derivatives have been proposed, using different carbohydrate starting 
materials. The two most exploited synthetic channels to  D-GalNAc and its derivatives are those 
based (a) on the C-4 epimerization of the largely and cheaply available D-GlcNAc,7 mimicking thus 
the biosynthetic pathway, and (b) on the amination at C-2 of D-galactose with formal retention of 
configuration.8-11 The first  D-Gal to  D-GalNAc transformation was described in 19768 by Paulsen 
and  co-workers  using  as  key  reaction  the  sodium  azide  opening  of  the  epoxide  ring  of  the 
intermediate 1,6:2,3-dianhydro-β-D-talopyranoside. Few years later, Lemieux and Ratcliffe9 used 
≠Part 25 of the series “Chemical Valorisation of Milk-derived Carbohydrates”. For part 24, see Ref. 1.
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the  azidonitration  of  tri-O-acetyl-D-galactal  for  the  synthesis  of  some  2-azido-2-deoxy-D-
galactopyranose  derivatives  and  free  D-GalNAc  (1b).  After  this  key  paper,  several  addition 
reactions to  D-galactal derivatives have been proposed to obtain D-GalNAc and its glycosides, as, 
the  Danishefsky’s  sulfamidoglycosylation,10 the  Gin’s  acetamidoglycosylation.11  Furthermore, 
specific synthesis of  D-GalNH2 starting from L-lyxose12 and, very recently,  D-tagatose13 have been 
proposed.
In  the  frame  of  a  general  project  on  the  synthesis  of  β-D-hexosaminyl-(1→4)-D-Glcp 
disaccharides,14 we  considered  the  synthesis  of  β-D-GalNAcp-(1→4)-D-Glcp (1a),  a  natural 
disaccharide present in minute amount in the bovine colostrum.15 The sole reported synthesis of 1a 
is  based  on  an  enzymatic  glycosylation  involving  a  β-1→4-N-acetylgalactosaminyltransferase.16 
However, the above synthesis do not appears suitable for preparative purposes. Presented herein is a 
new efficient  chemical  method for the preparation of the disaccharide  1a starting from lactose, 
involving a two-steps amination with overall retention of configuration at C-2’ (Chart 1), through 
the formation of β-D-talopyranoside intermediate of type 2. The potentiality of the method has also 
been  demonstrated  in  the  case  of  a  monosaccharide  β-D-galactopyranoside,  that  has  been 
transformed  into  a  know  precursor  of  free  D-GalNAc  (1b)  and  of  some  2-azido-2-deoxy-D-
galactopyranoside glycosyl donors. 
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Chart 1: Retrosynthetic approach for transforming a β -D-galactopyranoside unit into a D-GalNAc one.
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1b: X = OH
1a: X = 4-O-D-glucopyranosyl
2. Results and Discussion
A straightforward route to  β-D-GalNAcp-(1→4)-D-Glcp (1a) was envisaged (Scheme 1) taking 
advantage  from the  easily  availability  of  the  tetraacetonide  5,17 prepared  from its  C-2’  lactose 
epimer  (4)  through  a  completely  stereoselective,  high  yielding  (92%)  oxidation-reduction 
sequence.17 The activation of 5 was made by treatment with imidazyl sulfate (Im2SO2) and NaH in 
DMF at -30 °C, leading to the corresponding imidazylate 6, isolated pure by flash chromatography 
in 86% yield.  6 was then subjected to a SN2 substitution with NaN3  in DMF at 100 °C, obtaining, 
after flash chromatography, the azido derivative 7 in 94% yield. This result confirms the usefulness 
of the imidazylate leaving group for performing efficient substitution in position 2 of a pyranoside, 
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where other aryl and alkyl sulfonates are known to give unsatisfactory results.18
O CMe2
O
O
CMe2
O
O
O
O
O
OH
Me2C
(MeO)2CH
OMIP
O CMe2
O
O
CMe2
O
O
O
O
O
Me2C
(MeO)2CH
OMIP
N3
O CMe2
O
O
CMe2
O
O
O
O
O
NHAc
Me2C
(MeO)2CH
OH
O CMe2
O
O
CMe2
O
O
O
O
O
OSO2Im
Me2C
(MeO)2CH
OMIP
O OR
O
RO
OR
OR
O
RO
NHAc
OR
O CMe2
O
O
CMe2
O
O
O
O
O
OH
Me2C
(MeO)2CH
OMIP
5 6
78
1a: R = H
RO
9: R = Ac
a
b
cd
e
Scheme 1: Synthesis of β -D-GalNAcp-(1-->4)-D-Glcp disaccharide from lactose. Reagents and conditions: (a) Im2SO2, NaH, DMF, -30 °C,  
4 h (86%); (b) NaN3, DMF, 100 °C, 1.2 h (94%); (c) (1) NiCl2.6H2O, NaBH4, MeOH, 0 °C, room temp, 2 h; (2) Ac2O, MeOH, room temp,   
2 h (86%); (d) 80% aq AcOH, 80 °C, 4 h (90%); (e) Ac2O, Py, room temp, 18 h (95%).
Ref. 17
MIP = -C(OMe)Me2
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(92%)
The  reduction  of  the  azido  group  of  7 employing  nickel  chloride  hexahydrate  and  sodium 
borohydride,  afforded a  single  product  which was directly  submitted to  N-acetylation (Ac2O in 
MeOH). In the slightly acid reaction conditions the labile 6’-mixed acetal group was removed and 
compound 8 was obtained in 86% yield, after chromatographic purification. The target compound 
1a was instead prepared by complete deprotection of 8 using 80% aq AcOH at 80 °C: the reaction 
involves  the O-deisopropylidenation and the C-1 aldehydo group exposition with contemporary 
concomitant six membered ring closure. The structure of 1a as well as its anomeric composition (α/
β ratio about 2:3) were established on the basis of its NMR spectra. In particular,  the  1H NMR 
spectrum was identical to the reported one,15 while the  13C NMR signals, not yet  reported, were 
assigned by comparison (see Table 1) with those of α- and β-lactose,19 for the gluco portion, and 
those  of  methyl  2-acetamido-2-deoxy-β-D-galactopyranoside20 (Me  β-D-GalNAc,  not  showed). 
NMR analysis of the acetylated disaccharide 9, obtained treating 1a with Ac2O in pyridine for 18 h, 
further confirmed the parent compound structure.  It  is worth of note that  the transformation of 
lactose into the 2’-aminated analogue is obtained with a 7 steps process involving common reagents 
and simple manipulations in a very good overall yield (40%), certainly not easily achieved through 
chemical means starting from the two deprotected monosaccharide components. On the basis of this 
positive result,  the same protocol of C-2 amination with retention of configuration was applied 
(Scheme  2)  to  p-methoxyphenyl  3,4-O-isopropylidene-6-O-(1-methoxy-1-methylethyl)-β-D-
galactopyranoside  (10),  easily  obtainable  from  commercial  penta-O-acetyl-β-D-galactopyranose 
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through a simple sequence.21 Also in this case, the introduction of the azido group in position 2 was 
achieved  by  an  high  yielding  double  stereoselective  inversion  sequence,  providing  first  the 
preparation  of  the  talo-derivative  11 through  an  oxidation  at  C-2  (TPAP-NMO)  followed  by 
reduction of the crude uloside with NaBH4 in MeOH. The stereoselectivity of the reduction was 
again complete leading to the exclusive formation of  11 (81% isolated yield) due to the  β face 
shielding of the acetonide bridge, which completely inhibits the hydride attack on the same face. 
The axial hydroxyl function was then activated as sulfonyl imidazole (Im2SO2, and NaH in DMF at 
–30  °C)  and  12 was  obtained  in  92%  yield  after  chromatographic  purification.  The  second 
inversion-amination was performed, as described for the disaccharide analogue, by treatment with 
NaN3 in  DMF  at  100  °C,  obtaining  the  desired  azido  derivative  13 in  96%  yield.  The  two 
consecutive inversion of configuration were easily checked by 1H NMR, on the basis of J1,2 and J2,3 
values, 2.1 and 4.5 Hz respectively for the talo derivative 11, and 8.6 and 7.5 for the galacto one 
13.
Although some reported methods22 enable the direct transformation of the anomeric p-methoxy-
phenyl into other more reactive leaving groups, our next target was the known azido derivative 1523 
and its peracetylated derivative 16.24
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Scheme 2: Formal synthesis of  D-GalNAc and of 2-deoxy-2-azido-D-galactopyranosyl glycosyl donors. Reagents and conditions: 
(a) (1) TPAP, NMO, CH2Cl2, room temp, 2 h; (2) NaBH4, MeOH, 0 °C, 2 h (81% overall); (b) Im2SO2, NaH,  DMF, -30 °C, 20 min 
(92%); (c) NaN3, DMF, 100 °C, 2 h (96%); (d) (1) 80% aq AcOH, 80 °C, 2 h; (2) Ac2O, Py, room temp, 2 h (97% overall); (e) CAN,
3:1 Me2CO-H2O, 0 °C, room temp, 30 min (81%); (f) Ac2O, Py, room temp, 15 h (95%).
AcO OAc
15: R = H
16: R=Ac
MP= p-methoxyphenyl
f 1314
This goal was achieved by a first removal of the acetal functions by acid hydrolysis with 80% aq 
AcOH  and  acetylation  of  the  crude  residue  (Ac2O-Py),  obtaining  compound  14 in  almost 
quantitative  yield  (97%)  after  chromatographic  purification.  The  removal  of  the  anomeric  p-
methoxy phenyl was performed with CAN, leading to isolate (81% yield) the reducing derivative 
15, that was, finally, quantitatively transformed into the peracetate 16 by routine acetylation. 
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The transformation of  α-16 into  D-GalNAc hydrochloride has been described by Lemieux,9 while 
15 constitutes the key precursor of a series of 2-azido-2-deoxy-D-galactopyranose glycosyl donors.25
In conclusion, we have proposed an easy D-galactose into D-galactosamine transformation with 
complete  stereoselectivity  avoiding  thus  difficult  diastereoisomeric  separations.  Using  this  new 
methodology the first chemical synthesis of the β-D-GalNAcp-(1→4)-D-Glcp disaccharide has been 
achieved  with excellent  yield  starting  from lactose,  while  in  the  monosaccharide  series,  a  new 
synthesis  of  D-GalNAc  and  of  some  2-azido-2-deoxy-D-galactopyranosyl  donors  has  been 
accomplished, complementing thus the existing approaches. This strategy of amination with overall 
retention of configuration (double inversion) gave good results both in the mono- and disaccharide 
series and seems to have general applicability and good potentiality in the construction of complex 
β-D-GalNAc  containing  oligosaccharides  through  a  first  β-galactosylation  followed  by  its  C-2 
amination with retention of configuration. 
3. Experimental
3.1. General methods. 
General methods are those reported in Ref. 1. 1H NMR and 13C NMR spectra were recorded with 
an Avance II 250 spectrometer operating at 250.13 MHz (1H) and 62.9 MHz (13C) in the reported 
solvent  (internal  standard  Me4Si)  and  the  assignments  were  made,  when possible,  with  DEPT, 
HETCOR and COSY experiments. Compounds 517 and 1021 were prepared according to described 
procedures.
3.2. 4-O-[2-O-(1-imidazolylsulfonyl)-3,4-O-isopropylidene-6-O-(1-methoxy-1-methylethyl)-β-D-
talopyranosyl]-2,3:5,6-di-O-isopropylidene-aldeydo-D-glucose dimethyl acetal (6). 
To a suspension of 60% NaH in mineral oil (632 mg, 15.8 mmol) pre-washed with hexane under 
argon atmosphere and cooled to 0 °C, a soln of 517 (1.84 g, 3.17 mmol) in dry DMF (55 mL) was 
slowly added. The mixture was stirred at 0 °C for 30 min, cooled to –30 °C, treated with Im2SO2 
(940  mg,  4.74  mmol)  and  further  stirred  until  TLC  analysis  (EtOAc)  revealed  the  complete 
disappearance of the starting material (4 h). The reaction mixture was then cooled to –40 °C, excess 
of NaH was destroyed by addition of MeOH (0.5 mL) followed by 10 min stirring, and partitioned 
between Et2O (50 mL) and crushed iced-water. The organic phase was separated, and the aq layer 
extracted with Et2O (4  × 50 mL). The collected organic phases were dried (MgSO4), filtered and 
concentrated at diminished pressure. The flash chromatographic purification over silica gel of the 
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reaction product, eluting with 1:3 hexane-EtOAc + 0.1% of Et3N, gave pure 6 (1.93 g, 86%) as a 
syrup; [α]D +2.7 (c 1.06, CHCl3); Rf 0.33 (1:3 hexane-EtOAc); 1H NMR (CD3CN): δ 7.98 (dd, 1H, 
J2,4 1.3 Hz, J2,5 0.9 Hz, Im-H-2), 7.44 (dd, 1H, J4,5 1.7 Hz, Im-H-4), 7.05 (dd, 1H, Im-H-5), 4.92 (dd, 
1H, J1’,2’ 1.0 Hz, J2’,3’ 5.7 Hz, H-2’), 4.82 (d, 1H, H-1’), 4.40 (dd, 1H, J3’,4’ 5.8 Hz, H-3’), 4.36 (d, 1H, 
J1,2  6.0 Hz, H-1), 4.27 (dd, 1H, J2,3  7.7 Hz, H-2), 4.15 (dt, 1H,  J4,5 5.9 Hz, J5,6a=J5,6b 6.1 Hz, H-5), 
4.12 (dd, 1H, J4’,5’  2.7 Hz, H-4’), 4.04 (dd, 1H, J3,4 1.9 Hz, H-3), 3.94 (dd, 1H, J6a,6b 8.6 Hz, H-6b), 
3.84 (dd, 1H, H-6a), 3.80 (dd, 1H, H-4), 3.80 (ddd, 1H, J5’,6’a 6.5 Hz, J5’,6’b 6.3 Hz, H-5’), 3.63 (dd, 
1H, J6’a,6’b 9.6 Hz, H-6’b), 3.55 (dd, 1H, H-6’a), 3.41, 3.40 (2s, each 3H, 2 × OMe-1), 3.14 [s, 3H, 
C(OMe)Me2], 1.37, 1.36, 1.32, 1.30, 1.29, 1.28 (6s, each 3H, 3 × CMe2), 1.22, 1.20 [2s, each 3H, 
C(OMe)Me2]; 13C NMR (CD3CN): δ 138.1 (Im-C-2), 130.9 (Im-C-5), 120.1 (Im-C-4), 110.7, 110.3, 
109.2 (3  × CMe2),  106.5 (C-1),  100.9 [C(OMe)Me2],  99.1 (C-1'),  79.9 (C-2’),  78.5 (C-4),  77.9 
(C-3), 77.1 (C-5), 76.3 (C-2), 73.5 (C-5’), 71.9 (C-3’), 71.1 (C-4’), 66.5 (C-6), 60.3 (C-6’), 56.6, 
54.7 (2  × OMe-1), 48.9 [C(OMe)Me2], 27.3, 27.1, 27.0, 25.8, 25.4, 25.3 (3  × CMe2), 24.7, 24.6 
[C(OMe)Me2]. Anal Calcd for C30H50N2O15S: C, 50.69; H, 7.09; N, 3.94. Found: C, 50.89; H, 7.43; 
N, 5.29.
3.3.  4-O-[2-azido-2-deoxy-3,4-O-isopropylidene-6-O-(1-methoxy-1-methylethyl)-β-D-
galactopyranosyl]-2,3:5,6-di-O-isopropylidene-aldeydo-D-glucose dimethyl acetal (7). 
A soln of  6 (3.85 g, 5.41 mmol) and NaN3 (707 mg, 10.9 mmol) in dry DMF (100 mL) was 
stirred under argon atmosphere at 100 °C. After 1 h and 20 min TLC analysis (EtOAc) revealed the 
complete  disappearance  of  the  starting  material,  the  mixture  was  cooled  to  room  temp  and 
partitioned between satd aq NaHCO3 (50 mL) and Et2O (50 mL). The organic phase was separated 
and the aq layer extracted with Et2O (3 × 50 mL). The organic extracts were dried (MgSO4), filtered 
and concentrated at diminished pressure. Purification of the residue by flash chromatography over 
silica gel (7:3 hexane-EtOAc + 0.1% of Et3N) gave pure 7 (3.08 g, 94%) as a clear syrup; [α]D -30.0 
(c 1.0, CHCl3); Rf 0.64 (EtOAc); 1H NMR (CD3CN): δ 4.63 (d, 1H, J1’,2’ 8.5 Hz, H-1’), 4.34 (d, 1H, 
J1,2 6.0 Hz, H-1), 4.32 (t, 1H, J2,3 6.0 Hz, H-2), 4.25 (dt, 1H, J4,5 4.7 Hz, J5,6a=J5,6b 6.4 Hz, H-5), 4.15 
(dd, 1H, J3’,4’ 5.4 Hz,  J4’,5’  2.1 Hz, H-4’), 4.09 (dd, 1H, J6a,6b 8.5 Hz, H-6b), 4.06 (dd, 1H, J3,4 1.3 Hz, 
H-3), 4.01 (dd, 1H, H-6a), 3.94 (dd, 1H, H-4), 3.90 (dd, 1H, J2’,3’ 8.3 Hz, H-3’), 3.84 (ddd, 1H, J5’,6’a 
6.2 Hz, J5’,6’b 6.7 Hz, H-5’), 3.61 (dd, 1H, J6’a,6’b 9.4 Hz, H-6’b), 3.53 (dd, 1H, H-6’a), 3.39, 3.38 (2s, 
each 3H, 2  × OMe), 3.30 (dd, 1H, H-2’), 3.15 [s, 3H, C(OMe)Me2], 1.49, 1.40, 1.33, 1.32, 1.30, 
1.29 (6s, each 3H, 3 × CMe2), 1.29, 1.30 [2s, each 3H, C(OMe)Me2]; 13C NMR (CD3CN): δ 110.9, 
110.7, 108.9 (3  × CMe2), 106.4 (C-1), 102.2 (C-1'), 100.9 [C(OMe)Me2], 78.5 (C-3), 77.9 (C-5), 
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77.8 (C-3’), 76.7 (C-2), 76.2 (C-4), 73.8 (C-4’), 73.0 (C-5’), 67.3 (C-2’), 66.0 (C-6), 60.4 (C-6’), 
56.3, 54.4 (2 × OMe), 48.9 [C(OMe)Me2]; 28.4, 27.6, 27.1, 26.7, 26.3, 25.2 (3 × CMe2), 24.7, 24.5 
C(OMe)Me2]. Anal Calcd for C27H47N3O12: C, 53.54; H, 7.82; N, 6.94. Found: C, 53.47; H, 7.62; N, 
7.12.
3.4.  4-O-(2-acetamido-2-deoxy-3,4-O-isopropylidene-β-D-galactopyranosyl)-2,3:5,6-di-O-
isopropylidene-aldeydo-D-glucose dimethyl acetal (8). 
To a soln of 7 (1.40 g, 2.31 mmol) in MeOH (24 mL) cooled to 0 °C, NiCl2.6H2O (2.75 g, 11.5 
mmol) and NaBH4 (699 mg, 18.4 mmol) were added. The soln was warmed to room temp and 
stirred for 2 h. To the mixture were then added brine (50 mL) and, after 10 min, water (50 mL) and 
CHCl3  (50 mL). The organic phase was separated and the aq layer extracted with CHCl3 (4  × 50 
mL). The collected organic extracts were dried (MgSO4), filtered and concentrated at diminished 
pressure. The residue was dissolved in MeOH (30 mL), Ac2O (7.5 mL) was added and the mixture 
was stirred at  room temp for 2 h when TLC analysis  (EtOAc) showed the formation of a new 
product.  The  reaction  mixture  was  repeatedly  co-evaporated  with  toluene  (4  × 30  mL)  under 
diminished  pressure and purified  by flash chromatography over  silica  gel  (49:1  CHCl3-MeOH) 
affording pure 8 (1.09 g, 86%) as a clear syrup; [α]D +8.15 (c 1.46, MeOH); Rf 0.10 (EtOAc); 1H 
NMR (CD3CN): δ 6.47 (d, 1H, J2’,NH 8.9 Hz, NH), 4.58 (d, 1H, J1’,2’ 8.6 Hz, H-1’), 4.50 (dd, 1H, J1,2 
6.9 Hz, J2,3 7.0 Hz, H-1), 4.34 (d, 1H, H-1), 4.36-4.05 (m, 4H, H-5, H-3’, H-6’a, H-6’b), 3.97-3.70 
(m, 4H, H-5’, H-3, H-6a, H-6b), 3.51 (m, 2H, H-2, H-4), 3.43, 3.42 (2s, each 3H, 2 × OMe), 1.90 (s, 
3H,  MeCON), 1.45, 1.40, 1.32, 1.31, 1.28, 1.26 (6s, each 3H, 3  × CMe2);  13C NMR (CD3CN): δ 
170.6 (MeCO), 110.2, 110.0, 108.5 (3  × CMe2), 107.6 (C-1), 101.6 (C-1'), 78.6 (C-3), 77.4, 77.3 
(C-3’, C-5), 75.7, 75.6 (C-4, C-2), 74.6 (C-4’), 73.5 (C-5’), 65.6 (C-6), 62.5 (C-6’), 57.5, 54.6 (2 × 
OMe), 55.2 (C-2’), 28.2, 27.4, 26.8, 26.4, 26.3, 24.8 (3 × CMe2), 23.3 (MeCON). Anal Calcd for 
C25H43NO12: C, 54.63; H, 7.89; N, 2.55. Found: C, 54.72; H, 7.91; N, 2.58.
3.5. 4-O-(2-Acetamido-2-deoxy-β-D-galactopyranosyl]-α,β-D-glucopyranose (1a). 
A soln of 8 (450 mg, 0.82 mmol) in 80% aq AcOH (15 mL) was stirred at 80 °C for 4 h and then 
concentrated at diminished pressure by co-evaporation with toluene (4  × 35 mL). The residue was 
triturated with EtOAc to give an amorphous white solid (283 mg, 90%) constituted (13C NMR, D2O) 
by a 2:3 α/β anomeric mixture of 1a, as established on the basis of the integration of the H-1 signals; 
[α]D∞ = +55.8 (c 0.92, water); selected 1H NMR (D2O) data of α-1a: δ 5.21 (d, 1H, J1,2 3.8 Hz, H-1), 
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4.52 (d, 1H, J1’,2’ 8.4 Hz, H-1’); β-1a: δ 4.65 (d, 1H, J1,2 8.4 Hz, H-1), 4.51 (d, 1H, J1’,2’ 8.3 Hz, H-1’), 
3.27 (dd, 1H,  J2,3  8.8 Hz, H-2);  13C NMR (D2O) data of  α-1a and  β-1a see Table 1 and δ: 177.6 
(MeCO), 25.0 (MeCO). Anal. Calcd for C14H25NO11: C, 43.86; H, 6.57; N, 3.65. Found: C, 43.95; 
H, 6.59; N, 3.66.
3.6.  4-O-(2-Acetamido-2-deoxy–3,4,6-tri-O-acetyl-β-D-galactopyranosyl]-α,β-1,2,3,6-tetra-O-
acetyl-D-glucopyranose (9). 
1a (50 mg, 0.13 mmol) was dissolved in a 2:1 pyridine-Ac2O solution (3 mL) and the resulting 
soln was stirred at room temp for 18 h and then co-evaporated with toluene (3  × 5 mL) under 
diminished pressure. The flash chromatographic purification, eluting with EtOAc, afforded pure 9 
(84 mg, 95%) as an 1:1 α/β anomeric mixture, as established on the basis of the integration of the 
H-1 signals. 9 was a syrup; [α]D +16.0 (c 1.04, CHCl3); Rf 0.23 (EtOAc); 1H NMR (CD3CN) of α-9: 
δ 6.38 (d, 1H, J2’,NH 9.3 Hz, NH), 6.12 (d, 1H, J1,2 3.8 Hz, H-1), 5.32 (dd, 1H, J2,3 10.4 Hz, J3,4 8.7 
Hz, H-3), 5.02 (dd, 1H, J2’,3’ 11.3 Hz, J3’,4’ 3.5 Hz, H-3’), 4.90 (dd, 1H, H-2), 4.58 (d, 1H, J1’,2’ 8.4 
Hz, H-1’), 1.82 (s, 3H, MeCON); β-9: δ 6.36 (d, 1H, J2’,NH 9.3 Hz, NH), 5.74 (d, 1H, J1,2 8.3 Hz, 
H-1), 5.24 (m, 1H, H-3), 5.03 (dd, 1H, J2’,3’ 11.2 Hz, J3’,4’ 3.5 Hz, H-3’), 4.92 (dd, 1H, J2,3 9.7 Hz, 
H-2), 4.59 (d, 1H, J1’,2’ 8.4 Hz, H-1’), 1.83 (s, 3H, MeCON); cluster of signals for both anomers: δ 
4.40-3.95 (m, 14H, H-4, H-5, H-6a, H-6b, H-5’, H-6’a, H-6’b), 3.86 (m 2H, H-2’) 2.13, 2.08, 2.07, 
2.06, 2.05, 2.04, 2.03, 2.02, 2.01, 2.00, 1.98, 1.97, 1.96, 1.90 (14s, each 3H, 14 x  MeCOO);  13C 
NMR (CD3CN)  α-9:  δ 102.1 (C-1’), 89.6 (C-1), 76.1 (C-4), 71.3 (C-5, C-5’), 71.2 (C-3’), 70.6 
(C-3), 70.2 (C-2), 67.5 (C-4’), 62.4 (C-6), 62.1 (C-6’), 51.4 (C-2’); β-9: δ 102.1 (C-1’), 92.2 (C-1), 
75.8, 74.3, 73.3 (C-3, C-4, C-5), 71.3 (C-5’), 71.2 (C-3’), 70.3 (C-2), 68.5 (C-4’), 62.8 (C-6), 62.1 
(C-6’), 51.4 (C-2’); cluster of signals for both anomers: δ 171.4-169.9 (MeCO), 23.2 (MeCON), 
21.2-20.8 (MeCOO). Anal Calcd for C28H39NO18: C, 49.63; H, 5.80; N, 2.07. Found: C, 49.65; H, 
5.83; N, 2.08. 
3.7.  4-Methoxyphenyl  3,4-O-isopropylidene-6-O-(1-methoxy-1-methylethyl)-β-D-
talopyranoside (11). 
A mixture of  1021 (320 mg, 0.803 mmol), pre-dried 4-methylmorpholine  N-oxide (NMO, 165 
mg, 1.41 mmol) and 4Å powdered molecular sieves (500 mg) in anhyd CH2Cl2 (15 mL) was stirred 
for 30 min at room temp under argon atmosphere. Tetrapropylammonium perruthenate (TPAP, 14.1 
mg, 0.04 mmol) was then added and the resulting mixture was stirred for 2 h at room temp until 
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TLC (9:1 CH2Cl2-Me2CO) revealed complete oxidation of 10. The mixture was filtered through a 
celite-silica gel-celite triple alternate pad, the filter was washed in the order with CH2Cl2 and EtOAc 
and the organic phase was concentrated under diminished pressure. The residue was dissolved in 
MeOH (15 mL), NaBH4 (121.4 mg, 3.21 mmol) was added and the mixture was stirred at 0 °C. 
After 2 h TLC analysis (9:1 CH2Cl2-Me2CO) showed the complete disappearance of the 2-uloside. 
Water  (8 mL) was added and the resulting solution was stirred for additional  30 min and then 
extracted with CH2Cl2 (3  × 30 mL). The organic extracts were collected, dried (MgSO4), filtered 
and concentrated under diminished pressure. Purification of the residue by flash chromatography 
over silica gel (9:1 CH2Cl2-Me2CO + 0.1% Et3N) afforded pure  11 (259.2 mg, 81%) as a clear 
syrup;  [α]D  -49.5 (c 0.99, CHCl3); Rf 0.43 (9:1 CH2Cl2-Me2CO);  1H NMR (CD3CN): δ 7.02, 6.95 
(AA’XX’ system, 4H, Ar-H), 5.08 (d, 1H, J1,2 2.1 Hz, H-1), 4.37 (dd, 1H, J3,4 7.0 Hz, J2,3 4.5 Hz, 
H-3), 4.30 (dd, 1H, J4,5 2.1 Hz, H-4), 3.84 (ddd, 1H, J5,6a 6.9 Hz, J5,6b 5.2 Hz, H-5), 3.82 (dd, 1H, 
H-2), 3.73 (s, 3H, OMe), 3.59 (dd, 1H,  J6a,6b 10.0 Hz, H-6a), 3.55 (dd, 1H, H-6b), 3.12  [s, 3H, 
C(OMe)Me2],  1.52, 1.32 (2s, each 3H, CMe2), 1.28 (s, 6H,  C(OMe)Me2);  13C NMR (CD3CN): δ 
155.9, 152.4 (Ar-C), 118.9, 115.3 (Ar-CH), 110.5 (CMe2), 100.8 [C(OMe)Me2], 99.5 (C-1), 73.9 
(C-3), 72.8 (C-4), 72.1 (C-5), 67.0 (C-2), 61.4 (C-6), 56.1 (OMe-1), 48.8 [C(OMe)Me2], 25.8, 25.4 
(CMe2), 24.7, 24.6 [C(OMe)Me2]. Anal. Calcd for C20H30O8: C, 60.29; H, 7.59. Found: C, 60.47; H, 
7.61.
3.8.  4-Methoxyphenyl  2-O-(1-imidazolylsulfonyl)-3,4-O-isopropylidene-6-O-(1-methoxy-1-
methylethyl)-β-D-talopyranoside (12). 
To a suspension of 60% NaH in mineral oil (94 mg, 2.34 mmol) pre-washed with hexane under 
argon atmosphere and cooled to 0 °C a soln of 11 (186.8 mg, 0.469 mmol) in dry DMF (8 mL) was 
added. The mixture was stirred at 0 °C for 30 min, cooled to –30 °C, treated with Im2SO2 (139 mg, 
0.703 mmol) and further stirred at –30 °C. After 20 min TLC analysis (3:7 hexane-EtOAc) revealed 
the complete disappearance of the starting material. The reaction mixture was then cooled to –40 
°C, excess of NaH was destroyed by addition of MeOH (0.5 mL) followed by 10 min stirring, then 
partitioned between Et2O (16 mL) and crushed iced-water. The organic phase was separated, and 
the aq layer extracted with Et2O (2 × 16 mL). The collected organic phases were dried (MgSO4), 
filtered and concentrated at diminished pressure. The flash chromatographic purification over silica 
gel of the reaction product (2:3 hexane-EtOAc + 0,1% of Et3N) gave pure 12 (226.6 mg, 92%) as a 
clear syrup; [α]D +4.2 (c 1.18, CHCl3); Rf 0.22 (2:3 hexane-EtOAc); 1H NMR (CD3CN): δ 8.07 (dd, 
1H, J2,4 1.3 Hz, J2,5 0.8 Hz, Im-H-2), 7.50 (dd, 1H, J4,5 1.7 Hz, Im-H-4), 7.10 (dd, 1H, Im-H-5), 6.83, 
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6.72 (AA’XX’ system, 4H, Ar-H), 5.03 (dd, 1H,  J1,2 1.0 Hz,  J2,3 5.5 Hz, H-2), 4.93 (d, 1H, H-1), 
4.51 (dd, 1H, J3,4 5.8 Hz, H-3), 4.23 (dd, 1H, J4,5 2.7 Hz, H-4), 4.01 (ddd, 1H, J5,6a 7.4 Hz, J5,6b 4.7 
Hz, H-5), 3.71 (s, 3H, OMe), 3.65 (dd, 1H, J6a,6b 10.3 Hz, H-6a), 3.57 (dd, 1H, H-6b), 3.09 [s, 3H, 
C(OMe)Me2], 1.49, 1.33 (2s, each 3H, CMe2), 1.29, 1.28 [2s, each 3H,  C(OMe)Me2];  13C NMR 
(CD3CN): δ 156.3, 151.3 (Ar-C), 138.3 (Im-C-2), 131.1 (Im-C-5), 120.0 (Im-C-4), 118.6, 115.2 
(Ar-CH), 111.4 (CMe2), 100.8 [C(OMe)Me2], 97.3 (C-1), 79.3 (C-2), 73.8 (C-5), 71.9 (C-3), 71.4 
(C-4), 60.7 (C-6), 56.1 (OMe-1), 48.8 [C(OMe)Me2], 25.9, 25.4 (CMe2), 24.7, 24.6 [C(OMe)Me2]. 
Anal. Calcd for C23H32N2O10S: C, 52.26; H, 6.10; N, 5.30; S, 6.07. Found: C, 52.46; H, 6.18; N, 
5.33; S, 6.11.
3.9.  4-Methoxyphenyl  2-azido-2-deoxy-3,4-O-isopropylidene-6-O-(1-methoxy-1-methylethyl)-
β-D-galactopyranoside (13). 
A soln of 12 (91.2 mg, 0.173 mmol) and NaN3 (22.5 mg, 0.345 mmol) in dry DMF (4 mL) was 
stirred at 100 °C under argon atmosphere. After 2 h the mixture was cooled to room temp and 
partitioned between satd aq NaHCO3 (8 mL) and Et2O (15 mL). The organic phase was separated 
and the  aq  layer  extracted  with  Et2O (3  × 15  mL).  The  organic  extracts  were  collected,  dried 
(MgSO4),  filtered  and concentrated  at  diminished pressure.  Purification  of  the residue by flash 
chromatography over silica gel, eluting with 7:3 hexane-EtOAc + 0.1% of Et3N, gave pure 13 (71 
mg,  96%) as a clear syrup; [α]D +35.5 (c 0.67, CHCl3); Rf 0.32 (7:3 hexane-EtOAc);  1H NMR 
(CD3CN): δ 7.03, 6.92 (AA’XX’ system, 4H, Ar-H), 4.80 (d, 1H, J1,2 8.6 Hz, H-1), 4.19 (dd, 1H, J3,4 
5.3 Hz , J4,5 2.0 Hz, H-4), 4.02 (ddd, 1H, J5,6a 7.0 Hz, J5,6b 5.2 Hz, H-5), 3.98 (dd, 1H, J2,3 7.5 Hz, 
H-3), 3.75 (s, 3H, OMe), 3.64 (dd, 1H,  J6a,6b 10.0 Hz, H-6a), 3.63 (dd, 1H, H-2), 3.59 (dd, 1H, 
H-6b),  3.12  [s,  3H,  C(OMe)Me2],  1.52,  1.32  (2s,  each  3H,  CMe2),  1.31,  1.30  [2s,  each  3H, 
C(OMe)Me2];  13C NMR (CD3CN): δ 156.5, 151.8 (Ar-C), 119.1, 115.5 (Ar-CH), 111.1 (CMe2), 
101.4 (C-1), 100.8 [C(OMe)Me2], 77.9 (C-3), 73.9 (C-4), 73.3 (C-5), 66.0 (C-2), 60.9 (C-6), 56.1 
(OMe-1),  48.8  [C(OMe)Me2],  28.4,  26.4  (CMe2),  24.7,  24.6  [C(OMe)Me2].  Anal.  Calcd  for 
C20H31N3O7: C, 56.46; H, 7.34; N, 9.88. Found: C, 56.48; H, 7.38; N, 9.91.
3.10. 4-Methoxyphenyl 2-azido-2-deoxy-3,4,6-tri-O-acetyl-β-D-galactopyranoside (14). 
A soln of  13 (68 mg, 0.16 mmol) in 80% aq AcOH (3 mL) was stirred at 80 °C for 2 h, then 
concentrated at  reduced pressure and co-evaporated  with toluene (3  × 8 mL).  The residue was 
dissolved in a 2:1 pyridine-Ac2O soln (3 mL) and the resulting soln was stirred at room temp for 2 h 
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and then co-evaporated with toluene (3 × 8 mL). The flash cromatographic purification over silica 
gel (7:3 hexane-EtOAc) afforded pure  14 (67.8 mg,  97%) as a clear syrup; [α]D +6.02 (c 0.83, 
CHCl3); Rf 0.56 (2:3 hexane-EtOAc); 1H NMR (CD3CN): δ 7.03, 6.90 (AA’XX’ system, 4H, Ar-H), 
5.33 (dd, 1H, J3,4 3.4 Hz, J4,5 1.0 Hz, H-4), 5.00 (d, 1H, J1,2 8.1 Hz, H-1), 4.92 (dd, 1H, J2,3 10.8 Hz, 
H-3), 4.24-4.04 (m, 3H, H-6a, H-6b, H-5), 3.98 (dd, 1H, H-2), 3.75 (s, 3H, OMe), 2.21, 2.00, 1.99 
(3s, each 3H, 3 × MeCO); 13C NMR (CD3CN): δ 171.2, 171.1, 170.7 (3 × MeCO), 156.6, 151.6 (Ar-
C), 119.0, 115.6 (Ar-CH), 101.6 (C-1), 71.9 (C-5), 71.8 (C-3), 67.5 (C-4), 62.4 (C-6), 61.6 (C-2), 
56.1 (OMe-1), 20.8 (MeCO).  Anal. Calcd for C19H23N3O9: C, 52.17; H, 5.30; N, 9.61. Found: C, 
52.20; H, 5.33; N, 9.63.
3.11. 2-Azido-2-deoxy-3,4,6-tri-O-acetyl-α,β-D-galactopyranose (15). 
To a soln of 14 (67 mg, 0.153 mmol) in 3:1 Me2CO-water (6 mL), CAN (587 mg, 1.07 mmol) 
was added at  0 °C, the soln was warmed to room temp and stirred for 30 min.  The soln was 
concentrated to 3 mL, diluted with CH2Cl2 (25 mL), washed with sat aq NaHCO3 (2 × 15 mL), dried 
(MgSO4), filtered and concentrated under diminished pressure. Purification of the residue by flash 
chromatography over silica gel (7:3 hexane-EtOAc) afforded known 1523 (41 mg, 81%) as a clear 
syrup constituted (NMR, CDCl3) by a mixture of α- and β-anomers in 3:2 ratio calculated on the 
basis of the relative intensities of C-1 signals (δ 92.3 and 96.3, respectively);  [α]Dinizial +61.7, [α]D∞ 
+55.5 (c 0.91, MeOH); Rf 0.20 (7:3 hexane-EtOAc); 1H NMR (CDCl3) of α-15: δ 5.43 (d, 1H, J1,2 
3.3 Hz, H-1), 5.37 (dd, 1H, J2,3 10.0 Hz, J3,4 3.2 Hz, H-3), 4.47 (m, 1H, H-5), 3.74 (dd, 1H, H-2), 
3.91 (bs, 1H, OH-1); β-15: δ 4.83 (dd, 1H, J2,3 10.9 Hz, J3,4 3.3 Hz, H-3), 4.72 (dd, 1H, J1,2 7.8 Hz, 
J1,OH 5.3 Hz, H-1), 3.91 (m, 1H, H-5), 3.67 (dd, 1H, H-2), 4.58 (d, 1H, OH-1); cluster of signals for 
both anomers: δ 5.45 (m, 1H, H-4), 4.08-4.22 (m, 2H, H-6a, H-6b); 2.20-1.97 (m, 9H, 3 x MeCO); 
13C NMR (CDCl3)  α-15: δ 92.3 (C-1), 67.6 (C-4), 66.4, 66.3 (C-3, C-5), 57.9 (C-2);  β-15: δ 96.3 
(C-1),  71.1  (C-3),  70.8  (C-5),  68.3  (C-4),  61.9  (C-2);  cluster  of  signals  for  both  anomers:  δ 
170-7-170.0 (MeCO), 61.7, 61.3 (C-6), 20.7-20.5 (MeCO). Anal. Calcd for C12H19N3O8: C, 43.24; 
H, 5.75; N, 12.61. Found: C, 43.26; H, 5.76; N, 12.62.
3.12. 2-Azido-2-deoxy-1,3,4,6-tetra-O-acetyl-α,β-D-galactopyranose (16). 
A soln of 15 (32 mg, 0.10 mmol) in a 2:1 pyridine-Ac2O soln (2 mL) was stirred at room temp 
for 15 h and then co-evaporated with toluene (3  × 8 mL). The flash cromatographic purification 
over silica gel (1:1 hexane-EtOAc) afforded pure  16 (34 mg, 95%) as a clear syrup, constituted 
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(NMR, CDCl3) by a mixture of α- and β-anomers in 1:1 ratio calculated on the basis of the relative 
integral of H-1 signals (δ 6.28 and 5.50, respectively);  Rf 0.65 (1:1 hexane-EtOAc); [α]D +49.7 (c 
0.92, CHCl3); Lit24 [α]D +36.7 (c 1.6, CHCl3) for a 2:3  mixture of  α- and  β-anomers; NMR data 
were in full accordance with those reported.24 
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Table 1. 13C NMR chemical shifts of α- and β-1a and related compoundsa
Compound C-1’ C-2’ C-3’ C-4’ C-5’ C-6’ C-1 C-2 C-3 C-4 C-5 C-6
α-lactose 103.6 72.0 73.5 69.5 76.2 62.0 92.7 72.2 72.4 79.3 71.0 61.0
β-lactose 103.6 72.0 73.5 69.5 76.2 62.0 96.6 74.8 75.3 79.2 75.6 61.1
Me β-D-GalNAcp 103.1 53.0 71.9 68.6 75.8 61.7
α-1a 104.5 55.4 73.5 70.5 78.2 63.8 94.6 74.3 73.8 82.1 72.6 62.9b
β-1a 104.5 55.4 73.5 70.5 78.2 63.8 98.5 76.5 77.4b 81.9 77.3b 63.0b
aSpectra taken in D2O. Internal reference: 1,4-dioxane for lactose (Ref. 19) and Me-β-D-GalNAc (Ref. 20), TMSP for 1a. 
bAssigments may be reversed.
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